Skip to main content
OCGN logo

Ocugen, Inc.

OCGNNASDAQHealthcareBiotechnology

$0.78Today:- (-)1Y −49.14%

As of Oct 16, 2026 close

Market cap
$275.58M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.79$2.73
Volume (live)
-
Avg. volume (3M)
8.59M

Ocugen (OCGN) Income Statement

Ocugen reported revenue of $4.41M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 8.8% from $4.05M a year earlier. Ocugen posted a net loss of $67.85M, compared with a net loss of $54.05M a year earlier. Gross margin was 45.9% and operating margin -1425.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.49M, up 8.4% from the same quarter a year earlier.

Ocugen Income Statement Analysis

Values in millions USD

Scroll to see more
Ocugen, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue4.414.066.046.042.490.000.040.000.000.00
Cost of Revenue2.3932.130.7039.570.000.006.358.090.051.53
Gross Profit2.024.065.336.042.490.00-6.31-8.09-0.05-1.53
Operating Expenses
Research & Development39.7532.1339.5739.5756.1635.1113.358.0915.6315.57
Selling, General & Administrative27.5826.6931.9931.9935.4022.927.976.0810.209.38
Operating Expenses64.9458.8170.8671.5791.5658.037.976.0825.8424.95
Operating Income-62.92-54.76-65.53-65.53-89.07-58.03-14.29-14.16-30.11-24.95
Other Income/Expense
Interest Income0.921.252.502.501.400.000.000.000.000.00
Interest Expense5.190.690.00-0.000.08-0.721.770.160.13
Other Income/Expense-4.930.142.452.452.27-0.390.18-6.0811.89-1.46
Income
Income Before Tax-67.85-54.05-63.08-63.08-86.80-58.42-21.82-20.24-8.64-26.41
Income Tax Expense0.000.000.00-0.00-0.050.000.00-15.76-0.19
Net Income-67.85-54.05-63.08-63.08-86.80-58.37-21.82-20.24-8.64-26.41
Net Income - Continuous Operations-67.85-54.05-63.08-63.08-86.80-58.37-21.82-20.24-8.64-26.41
Net Income - Discontinued Operations----------
EBITDA-60.27-51.40-62.37-64.83-86.32-57.80-14.18-14.10-14.42-24.88
EBIT-62.92-53.37--65.53-89.07-58.03-14.29---
Depreciation & Amortization2.391.970.700.700.480.230.100.060.051.53
Earnings Per Share
Basic EPS--------2.00-14.00-70.00
Diluted EPS--------2.00-14.00-70.00
Basic Shares Outstanding300.17271.00244.33244.33214.60195.01112.2413.890.620.38
Diluted Shares Outstanding300.17271.00244.33244.33214.60195.01112.2413.890.620.38

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Ocugen Financial Statements

What was Ocugen's revenue in fiscal 2025?

Ocugen reported revenue of $4.41M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 8.8% from $4.05M a year earlier.

Is Ocugen profitable?

No. Ocugen reported a net loss of $67.85M in fiscal 2025. In fiscal 2024 it lost $54.05M.

What is Ocugen's operating margin?

Ocugen's operating income was −$62.92M on revenue of $4.41M in fiscal 2025, an operating margin of -1425.7%, compared with -1350.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition